Unidad de Coloproctología del Hospital Universitario de Getafe. #HospitaldeGetafe

Joined June 2021
Unidad de Coloproctología del HUGetafe retweeted
Perianal Crohn’s: which fistula can you actually close? Only one: a single tract, no proctitis. Sepsis first (drain + seton), then anti-TNF, then LIFT or flap - both heal 50-60%. 1 min with @AmyLightnerMD #THRIVE2027 👇 Free until tomorrow, 27 Oct - link below @escp_tweets
1
13
1
27
1,916
Unidad de Coloproctología del HUGetafe retweeted
🔥 What has changed in #diverticulitis management from 2018 → 2026? Less routine antibiotics, more individualized care, and important changes in recurrent disease and post-abscess management. 📚🔄 Great guideline update at #UEGWeek2026! 👏 @my_UEG #MedTwitter #Guidelines
🤖 Made with AI
29
5
85
5,804
Unidad de Coloproctología del HUGetafe retweeted
¿Te perdiste la sesión de ayer? 👀 🎥 Ya puedes consultar la sesión «Biomarcadores en el perioperatorio: ¿cómo pueden ayudar a la decisión clínica?» Recupera las claves para mejorar la toma de decisiones en cirugía. ▶️ Accede aquí: aecirujanos.es/Biomarcadores… @InesRPsurg
4
8
630
Unidad de Coloproctología del HUGetafe retweeted
This is Wonderful demonstration of "Intersphincteric resection for ultra low Rectal Cancer" and followed by Recto-anal Anastomosis by Robotic surgery. Intersphincteric resection (ISR) is indicated for carefully selected ultra-low rectal cancers located within 1–5 cm of the anal verge, where conventional low anterior resection cannot achieve a safe distal margin while preserving the sphincter complex. The procedure involves precise dissection in the intersphincteric plane between the internal and external anal sphincters, enabling complete mesorectal excision, adequate distal clearance, and restoration of continuity via coloanal anastomosis often stapled rather than abdominoperineal resection with permanent colostomy. Its importance lies in combining oncologic radicality with sphincter preservation, thereby improving quality of life by avoiding a permanent stoma in appropriate patients, provided neoadjuvant therapy, favorable tumor biology, and adequate sphincter function are present. Robotic assistance further enhances visualization and instrument dexterity within the confined pelvis, facilitating meticulous plane dissection and reducing conversion rates.
3
7
29
2,028
Unidad de Coloproctología del HUGetafe retweeted
Don’t let low rectal cancers send you into a spiral! Join us this Sunday at 7pm EST to hear more about Surgical Decision-Making in Low Rectal Cancer from Dr. Plasencia! Link: share.surgeonapp.com/public/…
2
7
543
Unidad de Coloproctología del HUGetafe retweeted
🆕 *ARTÍCULO NUEVO* · 14 de octubre de 2026 🩺 *Diverticulitis: lo que cambia en la guardia con la nueva guía EAES-SAGES 2026* _Surgical Endoscopy · 8 sociedades internacionales · método GRADE_ 💊 *Antibióticos:* en la diverticulitis aguda no complicada, con paciente inmunocompetente y estable, *sin antibiótico de rutina*. No mostraron beneficio claro en reingresos ni en recurrencias. 🔄 *Después de un absceso:* antes (guía 2018) no se operaba de rutina. *Ahora se sugiere sigmoidectomía electiva* cuando se recupera del primer episodio con absceso. Es la única recomendación con certeza moderada. No en frágiles ni inmunodeprimidos. 📆 *Recurrente con síntomas persistentes:* se sugiere *resección electiva* antes que seguir observando: menos recurrencias y mejor calidad de vida. 🔬 *Colonoscopia:* tras un primer episodio no complicado, *no de rutina*. Indícala según la edad y la clínica, si no tiene una en los últimos 5 años o si ya hubo más de un episodio. 🚑 *Complicada que necesita resección de urgencia:* sin shock séptico y con experiencia colorrectal, *anastomosis primaria ± ileostomía* antes que Hartmann o lavado (no en Hinchey IV). Con shock, fragilidad, inmunosupresión o sin esa experiencia: *Hartmann*. 📌 *Para llevar al quirófano* Se acabaron los automatismos: ni antibiótico para todos ni Hartmann para todos. Son recomendaciones condicionales: se decide con el paciente.
3
90
1
265
11,137
Unidad de Coloproctología del HUGetafe retweeted
Miss @SamGalgano 's fantastic rectal cancer MRI talk? Check out the visual abstract by @connieygan1 below. 📸 check out the lecture recording here: youtu.be/U9-keuK-2mE @UABRadiology #CRSVE #MedEd
27
1
65
8,978
Unidad de Coloproctología del HUGetafe retweeted
🚩 The Nordic parastomal hernia paradox: A regional survey of prophylaxis and repair🚩 Read the whole study as #OpenAccess👇️ journals.sagepub.com/doi/10.…
2
1
116
Unidad de Coloproctología del HUGetafe retweeted
Register Now! conceptosactuales.com Pelvic Floor Disorders needs your attention. Rectal cancer survivors living with LARS need better QoL. Learn more with @LARSCollab8950 members @luciacolorectal @PeterCh12345 @francomarinello @BoutrosMarylise @LilianaBordei @jules_cornish
3
3
119
Unidad de Coloproctología del HUGetafe retweeted
🦅Have you watched the video yet? EAGLE-2 (published in @bjsurgery) tested safe-anastomosis training in real-world practice across 60 countries. The result? Training was associated with: ✔️ Fewer anastomotic leaks ✔️ Fewer reoperations ✔️ Fewer readmissions And importantly, benefits appeared to persist even when some surgeons had completed the training two years earlier. 🎥 Watch Professor Dion Morton and Elizabeth Li discuss the study and the potential for scalable digital education to improve colorectal surgery worldwide: bjsacademy.com/bjs-academy/c… #EAGLE2 #Surgery #ColorectalSurgery #MedicalEducation #SurgicalInnovation
1
9
11
1,032
Unidad de Coloproctología del HUGetafe retweeted
Join us this Sunday on a hot topic: Fecal Incontinence and Surgical Decision Making with Dr. Zhang! Hope to see you there 💩 Link: share.surgeonapp.com/public/…
3
7
573
Unidad de Coloproctología del HUGetafe retweeted
Patient-centered online health information on diverticulitis: Assessing the readability, content, and overall quality 🔪 @herbchen @pferrada1 @PipeCabreraV @CiruAndes2 @SWexner @TomVargheseJr @sminaev2015 Link: americanjournalofsurgery.com…
1
7
11
1,108
Unidad de Coloproctología del HUGetafe retweeted
📌 ARTÍCULO DEL DÍA | ¿Cuándo cerrar la ileostomía de protección? Un metaanálisis 2026 comparó cierre temprano (≤30 días) vs cierre tardío (≥12 semanas) después de cirugía por cáncer de recto. Incluyó 9 ECA y 387 pacientes. 🔹 Resultado principal: el cierre temprano no aumentó significativamente la morbilidad global, complicaciones mayores, fuga anastomótica, readmisión, mortalidad, estancia hospitalaria ni LARS. 🔹 Pero atención a los números: complicaciones 20% vs 12% y fuga anastomótica 3,7% vs 0,6% a favor del cierre tardío. No fueron diferencias estadísticamente significativas, pero justifican seleccionar muy bien al paciente. 🔹 Cuando se analizaron únicamente cierres realizados dentro de las primeras 2 semanas, tampoco aparecieron diferencias significativas en fuga o complicaciones mayores, y la recuperación del tránsito intestinal fue algo más rápida. 🔹 Ventaja práctica: el cierre temprano reduce el tiempo viviendo con el estoma y dos estudios demostraron menores costos sanitarios. Un estudio encontró un retraso de ~5 días en iniciar quimioterapia adyuvante, aunque ambos grupos comenzaron antes de las 8 semanas. ⚠️ La clave no es "cerrar temprano a todos". Antes del cierre debe existir un posoperatorio favorable y haberse confirmado adecuadamente la integridad de la anastomosis. Los pacientes de alto riesgo requieren especial cautela. 🧠 Para recordar: Una ileostomía de protección no necesariamente tiene que permanecer 3 meses. En pacientes bien seleccionados, cerrarla precozmente puede ser una alternativa segura y menos costosa.
4
38
178
6,168
Unidad de Coloproctología del HUGetafe retweeted
Finding trusted, evidence-based guidance just got easier. The new Evidence-Based Guidelines and Expert Consensus channel on ASCRS U brings ASCRS-published Clinical Practice Guidelines and expert consensus statements together in one convenient location. Developed by ASCRS members and available at no cost to the public, these resources provide evidence-based guidance across key areas of colon and rectal surgery. 🔗 Explore the new channel on ASCRS U: bit.ly/3V9SeJ0
2
3
649
Unidad de Coloproctología del HUGetafe retweeted
TESAR Trial in 2 Slides: Completion TME vs. Organ Preservation in Early Rectal Cancer 🩺 ​When pathology reveals high-risk features (pT1 high-risk or low-risk pT2) after local excision, radical TME surgery has long been considered mandatory. However, radical surgery carries significant functional costs and high permanent stoma rates. ​The Phase III TESAR Trial evaluated whether mesorectum-targeted adjuvant chemoradiotherapy (CRT) can safely spare the rectum: ​🔹 Slide 1 — The Clinical Dilemma & Trial Design: Patients with high-risk pT1/low-risk pT2 rectal cancer after local excision were randomized (1:1) to either Adjuvant CRT (45 Gy + Capecitabine) or Completion TME surgery. ​🔹 Slide 2 — The 3-Year Results: • Overall Survival: 98.9% vs. 98.9% (Equivalent oncologic safety) • Permanent Stoma Rate: 2.6% (CRT) vs. 45.4% (TME) — an over 17-fold reduction in permanent stoma risk • Locoregional Recurrence: 5.0% (CRT) vs. 1.1% (TME) • Salvageability: 80% (4 of 5 local recurrences in the CRT arm were successfully salvaged with surgery), keeping unsalvageable recurrence at just 1.3%. ​The Bottom Line: Adjuvant CRT is an effective, evidence-backed organ-sparing alternative for patients who prioritize sphincter preservation or face elevated surgical risk. ​📚 Citation: The Lancet Gastroenterology & Hepatology. "Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial." ClinicalTrials.gov: NCT02371304. ​#ColorectalSurgery #RectalCancer #SurgicalOncology #OrganPreservation #MedEd #RadiationOncology #TESARTrial #LancetGastroHep
1
152
Unidad de Coloproctología del HUGetafe retweeted
🧬 HNPCC / Lynch Syndrome A quick clinical guide to the MMR genes, MSI, inheritance, associated cancers and diagnosis—essential knowledge for anyone dealing with colorectal cancer. 🎥 youtu.be/_AHrvO3YKSQ #LynchSyndrome #ColorectalCancer #MedEd – at Mumbai, India
6
12
957
Unidad de Coloproctología del HUGetafe retweeted
📽️ Hands-on Course on Watch and Wait — #ESCP26 Course Director Rodrigo Perez invites you to the Hands-on Course on Watch and Wait at ESCP 2026 in Prague Explore patient selection, surveillance strategies and the management of local regrowth in rectal cancer through highly interactive, case-based discussions led by experts in the field. 📅 Tue 22 Sept 2026 🕘 09:00–17:00 CEST 📍 Panorama Hall ⚠️ Limited spaces available Together, we’re #ShapingTheNext20Years. 🎟 Register now 👉 tinyurl.com/ESCP26-Watch-Wai…
1
4
1
12
1,098
Management of older adults with colorectal cancer – The state-of-the-art in 2026 - Journal of Geriatric Oncology geriatriconcology.net/articl…
1
134
Unidad de Coloproctología del HUGetafe retweeted
📑 Management of perioperative anaemia – five top tips 💬: Preoperative appropriate supplement, prior pausing of antiplatelets and anticoagulants, intraoperative tranexamic acid as standard of care, restrictive blood transfusion, postoperative IV iron when appropriate. - @GormsenJohanne ➡️ bjsacademy.com/bjs-academy/y… @bjsurgery
13
1
42
2,720